Ozempic vs Mounjaro 2026: Which GLP-1 Medication Works Best for Weight Loss?

If you're researching GLP-1 medications for weight loss, you've probably heard about both Ozempic and Mounjaro. Maybe your friend lost 40 pounds on one, but your sister had better results with the other. Or perhaps you're overwhelmed by conflicting information online and just want someone to explain the real differences in plain English.

Let's have that conversation. Both medications are genuinely effective for weight loss, but they work in slightly different ways, produce different average results, and may suit different people depending on your goals, tolerance, and how your body responds. Here's what you actually need to know in 2026.

What Ozempic and Mounjaro Actually Are

Ozempic is the brand name for semaglutide, a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1). This hormone naturally occurs in your gut and helps regulate blood sugar and appetite. When you take semaglutide, you're essentially giving your body more of this signal that says "I'm satisfied" after eating.

Mounjaro is the brand name for tirzepatide, which is slightly different. It mimics two hormones instead of one: both GLP-1 and another called GIP (glucose-dependent insulinotropic polypeptide). This dual action is why some doctors call it a "dual agonist" or "twincretin" medication.

Both were originally developed for type 2 diabetes, but doctors quickly noticed that people were losing significant weight on them. By 2026, millions of people use these medications specifically for weight management, even without diabetes.

How Much Weight Loss Can You Expect?

This is usually the first question, and it's important to be realistic. Individual results vary widely, but clinical trials and real-world data give us useful averages.

With Ozempic at the typical 2.4 mg weekly dose used for weight loss, people lose an average of 15-17% of their starting body weight over 68 weeks. For someone who starts at 200 pounds, that's roughly 30-34 pounds. Some people lose more, some less.

Mounjaro tends to produce slightly higher weight loss on average. At the higher maintenance doses (10 mg or 15 mg weekly), people lose an average of 18-22% of their starting body weight. That same 200-pound person might lose 36-44 pounds.

The key word here is "average." We see patients who lose more than these numbers, and others who lose less. Your results depend on many factors including your starting weight, diet changes, physical activity, sleep quality, stress levels, and your individual metabolism.

The Side Effects Story

Let's be honest: both medications can cause side effects, especially when you're starting or increasing your dose. The most common ones are gastrointestinal.

With Ozempic, you might experience nausea, occasional vomiting, diarrhea, or constipation. These symptoms are usually worst in the first few weeks and tend to improve as your body adjusts. Starting at a low dose and increasing slowly helps minimize this.

Mounjaro can cause similar GI side effects, and because it's a dual agonist, some people find the nausea slightly more pronounced, especially at higher doses. However, plenty of people tolerate Mounjaro beautifully while struggling with Ozempic, or vice versa. Bodies are individual.

Both medications slow down how quickly food leaves your stomach, which is part of how they work but also why they can cause digestive discomfort. Eating smaller portions, avoiding very fatty or spicy foods, and staying hydrated all help.

Serious side effects are rare but possible with both medications. These include pancreatitis, gallbladder issues, and potential thyroid concerns. Your doctor should review your personal and family medical history before prescribing either medication.

Dosing and How They're Taken

Both Ozempic and Mounjaro are once-weekly injections that you give yourself using a pre-filled pen. The injection is subcutaneous (just under the skin) in your abdomen, thigh, or upper arm. Most people find the process quick and relatively painless after the first few times.

Ozempic typically starts at 0.25 mg weekly for the first month, then increases to 0.5 mg, then 1 mg, and potentially up to 2 mg or 2.4 mg for weight loss. The gradual increase helps your body adjust.

Mounjaro starts at 2.5 mg weekly and can increase every four weeks: to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg. This wider range of doses gives doctors more flexibility to find your optimal level.

Cost Considerations in 2026

Brand-name Ozempic and Mounjaro remain expensive without insurance, often $900-1,200 per month. Insurance coverage varies widely. Some plans cover these medications for diabetes but not for weight loss alone, while others have begun covering them for obesity with prior authorization.

Compounded versions of semaglutide and tirzepatide have become increasingly available through legitimate telehealth providers and compounding pharmacies. These are typically much more affordable, starting around $99-300 per month depending on the dose. Compounded medications contain the same active ingredients but aren't made by the brand-name manufacturers.

Which One Is Right for You?

There's no universal "better" medication. The right choice depends on your individual situation.

You might consider starting with semaglutide (Ozempic) if you want to try a well-established GLP-1 medication with years of safety data, if you're sensitive to medications and want something that might be slightly gentler on your stomach, or if cost is a factor and compounded semaglutide is more accessible to you.

You might lean toward tirzepatide (Mounjaro) if you want the potentially higher average weight loss results, if you've tried semaglutide and hit a plateau or didn't respond as hoped, or if your doctor thinks the dual-agonist mechanism might be better suited to your metabolism.

Some people start with one and switch to the other based on their results and tolerance. There's no shame in that. Finding the right medication is a process, not a one-time decision.

For Women

Women often ask how these medications interact with hormones and menstrual cycles. While GLP-1 medications don't directly affect reproductive hormones, weight loss itself can change your cycle. Some women find their periods become more regular as they lose weight, particularly if they had PCOS. Others notice temporary irregularities during rapid weight loss. If you're of childbearing age, discuss birth control with your doctor, as these medications aren't recommended during pregnancy.

For Men

Men tend to see weight loss results slightly faster than women in the first few months, likely due to differences in metabolism and body composition. However, women often catch up by the one-year mark. Some men worry about decreased appetite affecting muscle mass. Prioritizing protein intake (at least 100-120 grams daily) and resistance training helps preserve lean muscle while losing fat on either medication.

From the Ozari Care Team

One of the most important factors in success with either medication isn't which one you choose, but how consistently you take it and how you support it with sustainable lifestyle changes. We encourage our patients to think of these medications as powerful tools that make healthy eating and movement feel more manageable, not as magic solutions that work in isolation.

Making Your Decision

Both Ozempic and Mounjaro are effective, well-studied medications that have helped millions of people achieve meaningful weight loss. The "best" choice is the one that works for your body, fits your budget, and helps you build a healthier relationship with food and your body.

Talk with a knowledgeable physician who can review your complete medical history, discuss your goals, and help you make an informed decision. And remember that this isn't a permanent, unchangeable choice. Your treatment can evolve as you learn what works best for you.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026